Join our study to help shape the future of heart health
- Start date
- Multiple start dates
- Therapy area(s)
- Heart health
- Location
- 2 clinics
- Compensation
- Compensation varies by study
- Status
-
Enrolling now
Requirements
Participants must meet the following inclusion criteria to be eligible for this clinical trial:
- Adults with history of ASCVD
About study
The purpose of the study is to test the safety and tolerability of the study drug on MACE-PLUS in participants ≥ 18 years of age with established ASCVD, or male participants ≥ 50 years of age and female participants ≥ 55 years of age who are at high risk of a first ASCVD event. This study is part of a program to confirm if the study drug will lower levels of LDL-C leading to the prevention of CV events in patients with established ASCVD or at high risk for a first ASCVD event. The target population consists of adult men and women who have incurred a prior CV event, with additional ASCVD risk factors, and LDL-C ≥ 60 mg/dL, or those without history of, but at high risk for a first ASCVD event who have an LDL-C ≥ 100 mg/dL. This is a research study, and your participation is voluntary. You may stop participating at any time.
Don’t meet one of the criteria above? You likely qualify for another study – please explore the full list at trialmed.com/find-a-study/
Submit request for call back.
You can sign up by calling the clinic’s call center or request a call back here.
Locations
| Location | Start date | Status |
|---|---|---|
| Minneapolis | Flexible start date |
Enrolling now
|
| Tucson | Flexible start date |
Enrolling now
|
